Results 71 to 80 of about 91,559 (219)

ESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study

open access: yesOpen Microbiology Journal, 2017
Introduction: Increase in extended-spectrum β-lactamases (ESBL) producing microbes in recent years has led to limitations of treatment options. This study aimed to assess the prevalence of ESBL producing E. coli and Klebsiella spp. at a tertiary hospital
P. Shakya   +4 more
semanticscholar   +1 more source

The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

open access: yesInfection and Drug Resistance, 2018
Introduction β-lactam and fluoroquinolone antibiotics are usually used for the treatment of urinary tract infections (UTIs). The aim of this study was to determine the prevalence of plasmid-mediated quinolone resistance (PMQR) and extended spectrum β ...
R. Azargun   +6 more
semanticscholar   +1 more source

In House Rapid, Simple Multiple‐Locus Variable‐Number Tandem Repeat Analysis (MLVA): A Reliable Tool for Enterobacter hormaechei Genotyping

open access: yesMicrobiologyOpen, Volume 14, Issue 6, December 2025.
We developed a new MLVA protocol targeting eight VNTR loci for the rapid and cost‐effective surveillance of Enterobacter hormaechei. Tested on diverse clinical isolates, it showed a discriminatory power comparable to MLST and was able to distinguish some strains within the same sequence type.
Claire Guillermard   +9 more
wiley   +1 more source

Extended-spectrum β-lactamases, transferable quinolone resistance, and virulotyping in extra-intestinal E. coli in Uruguay [PDF]

open access: yes, 2016
Introduction: To characterize extended-spectrum β-lactamases (ESBLs) and plasmid-mediated quinolone resistance (PMQR) genes in Escherichia coli isolates obtained from extra-intestinal samples in three Uruguayan hospitals.
Aguerrebere, Paula   +10 more
core   +3 more sources

Isolation of Extended-Spectrum β-lactamase- (ESBL-) Producing Escherichia coli and Klebsiella pneumoniae from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest Ethiopia

open access: yesThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2018
Background Klebsiella pneumoniae and Escherichia coli are the major extended-spectrum β-lactamase- (ESBL-) producing organisms increasingly isolated as causes of complicated urinary tract infections and remain an important cause of failure of therapy ...
Mengistu Abayneh   +2 more
semanticscholar   +1 more source

Antibacterial Potential of Actinomycete Extracts and Characterization of β‐Lactamase‐Producing Multidrug‐Resistant Uropathogenic Escherichia coli

open access: yesMicrobiologyOpen, Volume 14, Issue 6, December 2025.
Antibacterial Potential of Actinomycete Extracts Against Multidrug‐Resistant Escherichia coli in Babil Province, Iraq. ABSTRACT The increasing prevalence of multidrug‐resistant (MDR) uropathogenic Escherichia coli (UPEC) strains, particularly those producing β‐lactamase enzymes, complicates urinary tract infection (UTI) treatment and poses a ...
Hoda Khaledi, Nour Oude Obeid
wiley   +1 more source

Escherichia coli of sequence type 3835 carrying blaNDM-1, blaCTX-M-15, blaCMY-42 and blaSHV-12 [PDF]

open access: yes, 2015
New Delhi metallo-β-lactamase (NDM) represents a serious challenge for treatment and public health. A carbapenem-resistant Escherichia coli clinical strain WCHEC13-8 was subjected to antimicrobial susceptibility tests, whole genome sequencing and ...
Feng, Y   +5 more
core   +1 more source

OXA-1 &bgr;-lactamase and non-susceptibility to penicillin/&bgr;-lactamase inhibitor combinations among ESBL-producing Escherichia coli

open access: yesJournal of Antimicrobial Chemotherapy, 2018
Background ESBL-producing Escherichia coli have expanded globally since the turn of the century and present a major public health issue. Their in vitro susceptibility to penicillin/inhibitor combinations is variable, and clinical use of these ...
D. Livermore   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy